Q, T., DZ, M., J, B., FS, S., K, C., CK, K., . . . Y, Z. (2026). Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study. American journal of physical medicine & rehabilitation. https://doi.org/10.1097/PHM.0000000000003103
Chicago Style (17th ed.) CitationQ, Tate, et al. "Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study." American Journal of Physical Medicine & Rehabilitation 2026. https://doi.org/10.1097/PHM.0000000000003103.
MLA (9th ed.) CitationQ, Tate, et al. "Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study." American Journal of Physical Medicine & Rehabilitation, 2026, https://doi.org/10.1097/PHM.0000000000003103.